16/10/2026
Yesterday I went to Birmingham to represent and speak for Duchenne Care UK at the 'Moving the dial on osteoporosis in monitoring and management for Duchenne'.
A huge thank you to every speaker, chair, attendee and collaborator who made yesterday's meeting such an interesting day of discussion, collaboration and learning. We are grateful to Santhera Pharmaceuticals for sponsoring and making the meeting possible.
The programme was comprehensive, and the message that stayed with me is this: the challenge now is implementation. Bringing together early monitoring, timely intervention, growth and puberty management, fracture prevention, transition to adult services and coordinated care throughout life. Together they form a roadmap for better outcomes and better quality of life for everyone living with Duchenne, wherever they receive their care.
What makes this community special is the willingness of clinicians, researchers, industry and families to work together. Yesterday was another example of that collaboration in action and I'd especially like to acknowledge the commitment of healthcare professionals across the UK who continue to improve care for individuals and families affected by Duchenne through engagement in Duchenne Care UK.
As we left Birmingham, the shared determination was clear: keep moving the dial. Not just by discussing best practice, but by embedding it in routine care. Not just by identifying challenges, but by solving them together.
Because every improvement in bone health monitoring, every vertebral fracture detected earlier, every fracture avoided, every better-informed clinical decision translates into something that matters enormously better lives for people living with Duchenne.
Duchenne UK John Walton Muscular Dystrophy Research Centre